We should see good revenue from striate mid to late next year so would expect to see the sp respond. 2022 is looking very promising for occ. Striate, cellgro nerve and ati should make big steps next year. With cellgro rope hot on their heals, hopefully that will be launched around 2025, and by then we could be $10 if we attract the right investors.
We should see good revenue from striate mid to late next year so...
-
- There are more pages in this discussion • 441 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.5¢ | $186.3K | 503.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13513 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 30553 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |